These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8622006)

  • 1. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular toxicity in low-dose tamoxifen: a prospective study.
    Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
    Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
    Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal changes associated with tamoxifen treatment for breast cancer.
    Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
    Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen and ocular toxicity.
    Ah-Song R; Sasco AJ
    Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen retinopathy: does it really exist?
    Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term tamoxifen citrate use and potential ocular toxicity.
    Gorin MB; Day R; Costantino JP; Fisher B; Redmond CK; Wickerham L; Gomolin JE; Margolese RG; Mathen MK; Bowman DM; Kaufman DI; Dimitrov NV; Singerman LJ; Bornstein R; Wolmark N
    Am J Ophthalmol; 1998 Apr; 125(4):493-501. PubMed ID: 9559735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-induced ocular toxicity.
    Mihm LM; Barton TL
    Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ocular toxicity caused by tamoxifen: case report].
    Inada ET; Watanabe KP; Tanaka SG; Sakakisbara LA
    Arq Bras Oftalmol; 2005; 68(4):554-6. PubMed ID: 16322846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudocystic foveal cavitation in tamoxifen retinopathy.
    Doshi RR; Fortun JA; Kim BT; Dubovy SR; Rosenfeld PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1291-1298.e3. PubMed ID: 24582991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for tamoxifen ocular toxicity: a prospective study.
    Therssen R; Jansen E; Leys A; Rutten J; Meyskens J
    Eur J Ophthalmol; 1995; 5(4):230-4. PubMed ID: 8963159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystalline maculopathy: a rare complication of tamoxifen therapy.
    Srikantia N; Mukesh S; Krishnaswamy M
    J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
    Bourla DH; Sarraf D; Schwartz SD
    Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
    Heier JS; Dragoo RA; Enzenauer RW; Waterhouse WJ
    Am J Ophthalmol; 1994 Jun; 117(6):772-5. PubMed ID: 7880223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular adverse reactions to tamoxifen--a review.
    Dulley P
    Ophthalmic Physiol Opt; 1999 Mar; 19 Suppl 1():S2-9. PubMed ID: 10645394
    [No Abstract]   [Full Text] [Related]  

  • 17. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
    Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
    J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye problems in breast cancer patients treated with tamoxifen.
    Paganini-Hill A; Clark LJ
    Breast Cancer Res Treat; 2000 Mar; 60(2):167-72. PubMed ID: 10845279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unusual symptoms for tamoxifen-associated maculopathy].
    Hager T; Hoffmann S; Seitz B
    Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal.
    Andreanos K; Oikonomakis K; Droutsas K; Petrelli M; Kymionis G
    Cornea; 2017 Mar; 36(3):377-378. PubMed ID: 27918356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.